FT

AstraZeneca US trial shows 79% efficacy against Covid

Trial found no increased risk of blood clots and 100% efficacy against severe or critical disease

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button